Cooperation with the pharmaceutical industry
Clinical studies
The path to new drugs and innovative treatment concepts for patients is a long one, as the drugs have to be further developed and tested in controlled clinical trials. This process requires a great deal of knowledge, time and money in order to bring new cancer drugs and innovative treatment options to cancer patients.
Information for
Affected and interested parties
For the benefit of society and with the common goal of continuously improving the care of cancer patients in Bavaria, the BZKF cooperates with the pharmaceutical industry in Bavaria and throughout Germany in various areas.
In an international comparison of the top locations for clinical trials, Germany has been falling further and further behind for years due to complex bureaucratic procedures, lengthy decentralized approval processes and a lack of digitalization. Countermeasures need to be taken here and processes need to be optimized. The research-based pharmaceutical companies are an important building block in this process. The BZKF works together with representatives of the pharmaceutical industry in various areas to further strengthen Bavaria as a business and science location and to promote innovative oncology research.
